Cyclin C/CDK8 and cyclin H/CDK7/p36 are biochemically distinct CTD kinases
- 28 January 1999
- journal article
- Published by Springer Nature in Oncogene
- Vol. 18 (4) , 1093-1102
- https://doi.org/10.1038/sj.onc.1202399
Abstract
Oncogene is one of the world’s leading cancer journals. It is published weekly and covers all aspects of the structure and function of Oncogenes. Oncogene also publishes 8 Reviews issues a year, on a broad range of topics.Keywords
This publication has 81 references indexed in Scilit:
- Cellular effects of olomoucine, an inhibitor of cyclin‐dependent kinasesPublished by Wiley ,2012
- Requirement for Phosphorylation of RNA Polymerase II C-Terminal Domain in Transcription Is Both Transcript Length and Promoter DependentBiochemical and Biophysical Research Communications, 1996
- Olomoucine, an inhibitor of the cdc2/cdk2 kinases activity, blocks plant cells at the G1 to S and G2 to M cell cycle transitionsFEBS Letters, 1994
- Phosphorylation of RNA polymerase II C-terminal domain and transcriptional elongationNature, 1994
- Potent Inhibition of Cdc2 Kinase Activity by the Flavonoid L86-8275Biochemical and Biophysical Research Communications, 1994
- Phosphorylation of C-terminal domain of RNA polymerase II is not required in basal transcriptionNature, 1993
- CTD kinase associated with yeast RNA polymerase II initiation factor bCell, 1991
- The C-terminal domain of RNA polymerase II of the malaria parasite Plasmodium bergheiBiochemical and Biophysical Research Communications, 1991
- Phosphorylation of RNA polymerase by the murine homologue of the cell-cycle control protein cdc2Nature, 1989
- 5,6-Dichloro-1-β-D-ribofuranosylbenzimidazole inhibits a HeLa protein kinase that phosphorylates an RNA polymerase II-derived peptideBiochemical and Biophysical Research Communications, 1989